Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2002 2
2003 1
2004 3
2005 3
2006 2
2007 1
2008 2
2009 1
2010 2
2011 3
2012 6
2013 2
2014 2
2015 4
2017 2
2018 4
2020 10
2021 8
2022 16
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.
Mrak D, Sieghart D, Simader E, Tobudic S, Radner H, Mandl P, Göschl L, Koblischke M, Hommer N, Wagner A, Mayer M, Schubert L, Hartl L, Kozbial K, Hofer P, Kartnig F, Hummel T, Kerschbaumer A, Deimel T, Puchner A, Gudipati V, Thalhammer R, Munda P, Uyanik-Ünal K, Zuckermann A, Novacek G, Reiberger T, Garner-Spitzer E, Reindl-Schwaighofer R, Kain R, Winkler S, Smolen JS, Stiasny K, Fischer GF, Perkmann T, Haslacher H, Zeitlinger M, Wiedermann U, Aberle JH, Aletaha D, Heinz LX, Bonelli M. Mrak D, et al. Among authors: aberle jh. Nat Commun. 2022 Sep 12;13(1):5362. doi: 10.1038/s41467-022-33036-y. Nat Commun. 2022. PMID: 36097029 Free PMC article. Clinical Trial.
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer TM, Merrelaar A, Eder M, Regele F, Doberer K, Spechtl P, Aschauer C, Koblischke M, Paschen C, Eskandary F, Hu K, Öhler B, Bhandal A, Kleibenböck S, Jagoditsch RI, Reiskopf B, Heger F, Bond G, Böhmig GA, Strassl R, Weseslindtner L, Indra A, Aberle JH, Binder M, Oberbauer R. Reindl-Schwaighofer R, et al. Among authors: aberle jh. JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372. JAMA Intern Med. 2022. PMID: 34928302 Free PMC article. Clinical Trial.
CD4 T cell responses to flaviviruses.
Aberle JH, Koblischke M, Stiasny K. Aberle JH, et al. J Clin Virol. 2018 Nov;108:126-131. doi: 10.1016/j.jcv.2018.09.020. Epub 2018 Oct 3. J Clin Virol. 2018. PMID: 30312909 Free PMC article. Review.
ACE2 Elevation in Severe COVID-19.
Reindl-Schwaighofer R, Hödlmoser S, Eskandary F, Poglitsch M, Bonderman D, Strassl R, Aberle JH, Oberbauer R, Zoufaly A, Hecking M. Reindl-Schwaighofer R, et al. Among authors: aberle jh. Am J Respir Crit Care Med. 2021 May 1;203(9):1191-1196. doi: 10.1164/rccm.202101-0142LE. Am J Respir Crit Care Med. 2021. PMID: 33600742 Free PMC article. No abstract available.
The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R, Hödlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, Schörgenhofer C, Rumpf B, Karolyi M, Traugott MT, Abrahamowicz A, Tinhof V, Mayfurth H, Rathkolb V, Mußnig S, Schmölz L, Ullrich R, Heinzel A, König F, Binder C, Bonderman D, Strassl R, Puchhammer-Stöckl E, Gorkiewicz G, Aberle JH, Jilma B, Wenisch C, Poglitsch M, Oberbauer R, Zoufaly A, Hecking M. Reindl-Schwaighofer R, et al. Among authors: aberle jh. Sci Rep. 2022 Nov 22;12(1):20117. doi: 10.1038/s41598-022-24628-1. Sci Rep. 2022. PMID: 36418458 Free PMC article.
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination.
Graninger M, Camp JV, Aberle SW, Traugott MT, Hoepler W, Puchhammer-Stöckl E, Weseslindtner L, Zoufaly A, Aberle JH, Stiasny K. Graninger M, et al. Among authors: aberle jh. Front Immunol. 2022 May 30;13:888794. doi: 10.3389/fimmu.2022.888794. eCollection 2022. Front Immunol. 2022. PMID: 35711424 Free PMC article.
Human recombinant soluble ACE2 in severe COVID-19.
Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, Neuhold S, Haider D, Stiasny K, Bergthaler A, Puchhammer-Stoeckl E, Mirazimi A, Montserrat N, Zhang H, Slutsky AS, Penninger JM. Zoufaly A, et al. Among authors: aberle jh. Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24. Lancet Respir Med. 2020. PMID: 33131609 Free PMC article. No abstract available.
The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021.
Graninger M, Hubmer S, Riederer F, Kettner S, Hauk M, Auf T, Aberle JH, Stiasny K, Aberle SW, Camp JV. Graninger M, et al. Among authors: aberle jh. Open Forum Infect Dis. 2022 May 16;9(7):ofac255. doi: 10.1093/ofid/ofac255. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35873290 Free PMC article.
79 results